⏰<48h till the next AASLD @liver_club ELLC session! 📜Exciting articles (Donor Simvastatin and recip graft outcomes, Renal fxn with combo Tac-Siro, LSMs in LTRs) and all-🌟 experts kym watt Juliet Emamaullee MD PhD Manhal Izzy Register here: bit.ly/40WW1I6 #livertwitter

More great news for #fibrolamellarcarcinoma patients with Zach Travis, Alli O'Neill, MD Memorial Sloan Kettering Cancer Center MSK Department of Medicine Ghassan Abou-Alfa UCSF Helen Diller Family Comprehensive Cancer Ctr John Gordan and more, with Fibrolamellar Cancer support. nature.com/articles/s4169…. Hope next is the treatment and cure!

Join us on June 15 for our Challenging Liver Cases series hosted by the Clinical Practice SIG. In this session, we present two unique challenging liver cases. Register online at bit.ly/3IJNYHl. #LiverTwitter Hassan Azhari, MD Qasim Khan (He/Him/His)

📢 #livertwitter Please join us on June 15, 2023 🗓️ at 5 pm EST for the next AASLD Challenging Liver Cases session with 🌟 expert commentary by Juan Pablo (JP) Arab, MD  Amol Mujoomdar and Hassan Azhari, MD! Great cases🏥, even better discussion! Register below 📝:

Excited to share our study on exocrine pancreatic insufficiency related to immune checkpoint inhibitors, led by our star (former) GI fellow Deepika Satish Memorial Sloan Kettering Cancer Center Michael Postow academic.oup.com/oncolo/advance… 1/2

Almost ready to start! Don't miss it! Qasim Khan (He/Him/His) Hassan Azhari, MD Amol Mujoomdar AASLD #LiverTwitter

Always more to learn from master clinician and educator Will Sanchez, MD | Hepatologist Mayo Clinic Gastroenterology & Hepatology #TLM2023

Hassan Azhari, MD Mayo Clinic Gastroenterology & Hepatology Nothing more satisfying than to see former fellows in Boston at #TLM2023 and hear about how their careers in #hepatology are flourishing. Brings me so much joy!

Day 2 of AASLD #TLM23 is in the bag! Time to unwind with Mayo Clinic Gastroenterology & Hepatology brothers Jerry Chin, MBBS, FRACP and Hassan Azhari, MD! Let's go Toronto Raptors! #WeTheNorth #GoodTimes

Great results from the first clinical trial testing NALTREXONE vs placebo in alcohol-related cirrhosis, today at #TLM23 : 🔸Naltrexone is well tolerated 🔸It favors abstinence 🔸It reduces by 50% new onset decompensation AASLD #livertwitter #MedTwitter ILBS_University

Now Online❗️ AASLD Practice Guidance on risk stratification and management of portal hypertension and varices in cirrhosis 👉 bit.ly/3uypo8v #LiverTwitter HEPATOLOGY Journal

Not too late to register! Our March 15 Memorial Sloan Kettering Cancer Center CME Course on Approach to GI Premalignant and Malignant Disorders - featuring guest speaker Dr. Greg Gores from Mayo Clinic Gastroenterology & Hepatology mskcc.cloud-cme.com/course/courseo…

📢You were “today years old” when Madrigal Pharmaceuticals’s #Resmetirom became the 1st FDA-approved drug for MASH🥳🙌. A big day for the field and our patients! Looking fwd to Health Canada and PHAC Ontario Ministry of Health following suit! Juan Pablo (JP) Arab, MD  Hassan Azhari, MD Jerry Chin, MBBS, FRACP fda.gov/news-events/pr…

Congrats dear #Brazil oncology speciality colleagues for visiting Memorial Sloan Kettering Cancer Center MSK Department of Medicine May 23 24. Thanks Hassan Azhari, MD Anne Covey MD FSIR James J. Harding, MD Carla_Hajj + Danny Khalil for contributions. Great delight for Ghassan Abou-Alfa to present certificates on behalf of Jeff Drebin

On the margin of APPLE, Memorial Sloan Kettering Cancer Center MSK Department of Medicine Medical Diplomacy Debriefing led by Larry Norton Ghassan Abou-Alfa and United Nations Partnership The Defeat-NCD Partnership Arvind Bhardwaj in the Wardroom on board of Battleship Missouri in PearlHarborNPS . More to come!

And we’re off! Great start to APPLE 2024 with Dr. Ghassan Abou-Alfa and Dr. Linda Wong MSK Department of Medicine Memorial Sloan Kettering Cancer Center

The increasing burden of MASLD is a worldwide issue and major risk factor for HCC - review of work being done and what remains to be done with Dr. Hashem el- Serag at APPLE 2024

Exciting imaging and serologic testing advances coming to HCC surveillance beyond ultrasound and AFP - review with Dr. Amit G Singal at APPLE 2024

From another Asian country at APPLE 2024 in Honolulu Hawaii: Egypt at the merge of Asia & Africa Ashraf Omar on successful 🇪🇬 #HCV efforts. Thnks Sharlene Gill, MD, MPH, MBA, FASCO + Masafumi Ikeda for an excellent session along with Memorial Sloan Kettering Cancer Center MSK Department of Medicine Hassan Azhari, MD and more!

Arguably one of the most important figures in Hepatology in 2024. How to select appropriate patients for MASH Rx. Nothing is perfect but action is needed and liver biopsy is ☠️ Mazen Noureddin, MD, MHSc EASL Education Aleksander Krag AASLD President Madrigal Pharmaceuticals Novo Nordisk US Medical Echosens